The market-leading software for safe, effective anticoagulation management
We have 20 years of experience in the NHS working closely with GP practices, pharmacies, out-of-hours services and hospitals.
INRstar supports the induction, dosing and review of patients on all vitamin K antagonist and both direct and new oral anticoagulant drugs (DOACs / NOACs).
We currently support over 2,700 locations across the UK treating over 300,000 patients with higher than average TTR:
81.20% of patients managed in INRstar have a TTR greater than 65%
The average TTR across all INRstar locations is 75.69%